Apollo Ingredients Ltd (503639) — Multibagger Analysis

AI research on 1 Expansion / Order-win announcement by Apollo Ingredients Ltd since August 2026 — deal magnitude, revenue and EPS impact, execution risk, and the actual return since each announcement measured from the next trading day's open and benchmarked against the Nifty Smallcap 250.

Board Meeting - Outcome of Board Meeting

10 August 2026 · Expansion · Possible · Diversified Commercial Services · score 65/100

Deal

Deal value—

Deal vs businessQ1 FY27 quarterly revenue of ₹5.27 Cr equals 105% of prior full-year TTM revenue (₹5.0 Cr)

Execution period1.0 yr

Fundamental gradeB

AI projections

Revenue uplift (yr1 / steady)200.0% / 250.0%

EPS uplift350.0%

Upside base / bull / bear45.0% / 110.0% / -35.0%

Horizon12-24 months

Realized market record

Entry — next-day open (11 Aug 2026)₹134.75

Latest close (16 Sep 2026)₹97.02

Return since-28.0%

α vs Smallcap 250-25.2%

α vs own sectorshown once held 90+ days — Diversified Commercial Services median is +0.1% over 22 matured picks

Positives

Q1 FY27 revenue of ₹5.27 Cr surged 836% YoY and exceeded full FY26 TTM revenue (₹4.9 Cr) in a single quarter.
Q1 FY27 PAT jumped to ₹1.22 Cr, translating to an annualized PAT run-rate of ~₹4.88 Cr.
Zero debt balance sheet with high promoter equity holding of 66.58%.
Substantial reduction in forward P/E valuation multiples upon inclusion of Q1 FY27 earnings.

Risks

Extremely short operating history with fewer than 8 quarters of detailed financials post-pivot from Indsoya Ltd.
Historical revenue lumpiness (e.g., Dec 2025 ₹2.77 Cr dropped to Mar 2026 ₹1.01 Cr), raising questions about sustainability.
Micro-cap illiquidity (market cap ₹145 Cr) and operational risk in maintaining high gross margins during volume expansion.
Working capital stress if customer payment terms lengthen as sales scale up.

Full AI brief

Financial & Multibagger Analysis: Apollo Ingredients (503639)

Analysis Date: 2026-08-10

1. Catalyst & Ramp-Aware Impact Math

Headline Event: Q1 FY27 earnings result reporting total revenue of ₹5.27 Cr (+836% YoY) and Net Profit of ₹1.22 Cr (vs ₹-0.09 Cr loss YoY).
Baseline Context (Pre-Q1 FY27):
TTM Revenue: ₹5.0 Cr
TTM Net Profit: ₹1.0 Cr (EPS ₹0.82)
Market Cap (at ₹140.3): ₹145 Cr
Pre-announcement Trailing P/E: 171.1x
Updated Trailing Financials (Q2 FY26 to Q1 FY27):
New TTM Revenue = ₹0.57 Cr (Q2) + ₹2.77 Cr (Q3) + ₹1.01 Cr (Q4) + ₹5.27 Cr (Q1 FY27) = ₹9.62 Cr
New TTM PAT = ₹0.02 Cr + ₹0.87 Cr + ₹0.07 Cr + ₹1.22 Cr = ₹2.18 Cr
Adjusted Trailing P/E = ₹145 Cr / ₹2.18 Cr = 66.5x
Run-Rate Trajectory (Annualized Q1 FY27):
Annualized Revenue Run-Rate: ₹5.27 Cr × 4 = ₹21.08 Cr (~320% higher than FY26)
Annualized PAT Run-Rate: ₹1.22 Cr × 4 = ₹4.88 Cr
Forward P/E (on annualized Q1 PAT): 29.7x

2. Industry Context & Capital Intensity

Sector: Diversified Commercial Services / Ingredients.
Capital Intensity: Low. Working capital management is the key constraint rather than heavy capex.
Execution Difficulty: Moderate. Scaling ingredients distribution requires strong sourcing networks and inventory management.

3. Fundamental & Quality Assessment

SEPA Grade: B (Turnaround/Emerging Micro-cap).
Balance Sheet: Debt-free (D/E 0.00), Net Worth ₹7 Cr, ROCE 22.9%.
Promoter Holding: 66.58% (stable over previous 4 quarters).
Operational Consistency Risk: Quarterly revenues show structural volatility (Jun 25: ₹0.56 Cr, Sep 25: ₹0.57 Cr, Dec 25: ₹2.77 Cr, Mar 26: ₹1.01 Cr, Jun 26: ₹5.27 Cr). The durability of ₹5+ Cr quarterly run-rates must be monitored across upcoming quarters.

4. Valuation Scenarios & Return Profile (12-24 Months)

Base Case (Upside: +45%): Company maintains average quarterly revenue of ~₹4.5 Cr (~₹18 Cr FY27 revenue), achieving PAT of ₹3.6 Cr (~20% NPM). Applying a conservative P/E multiple of 58x yields a Target Market Cap of ₹210 Cr (~₹203/share).
Bull Case (Upside: +110%): Q1 FY27 run-rate accelerates to ₹6 Cr/quarter (~₹24 Cr revenue, ₹5.2 Cr PAT). Market re-rates the stock to 60x forward P/E given rapid growth, yielding a Target Market Cap of ₹312 Cr (~₹300/share).
Bear Case (Downside: -35%): Q1 surge proves to be a lumpy, non-recurring order cycle; quarterly revenue averages ~₹2.0 Cr (~₹8 Cr annual revenue, PAT ₹1.2 Cr). P/E compresses to 78x on lower earnings, bringing Market Cap to ₹94 Cr (~₹91/share).

5. Verdict Rationale

Verdict: POSSIBLE
Score: 65/100
Confidence: 0.50 (Bounded due to <8 quarters of financial history and revenue lumpiness).
Conclusion: The Q1 FY27 earnings turnaround is significant, with one quarter delivering more revenue than the entire previous year. However, given the company's recent structural change (formerly Indsoya Ltd), short history, and micro-cap status, a conservative stance is maintained until revenue persistence is proven over 2-3 additional quarters.

Analysis as of 2026-08-10 (price ₹140.30) · AI research, not investment advice.

FollowTelegram

Verdicts and projections on this page are produced by an AI model from Apollo Ingredients Ltd's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.